deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT05150808

Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania

WHO Phase III Evaluation of Vectron T500 (Broflanilide 50WP) for IRS in Tanzania

Sponsor: Kilimanjaro Christian Medical Centre, Tanzania

Conditions Malaria,Falciparum
Interventions IRS insecticide: Vectron T500
Updated 4 times since 2022 Last updated: Nov 26, 2021 Started: Oct 1, 2020 Primary completion: Jun 30, 2022 Completion: Dec 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Malaria,Falciparum and is currently ongoing. Kilimanjaro Christian Medical Centre, Tanzania leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2022 – ~Dec 2023 · 23 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Dec 2023 — Jul 2024 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  4. Jan 2022 — Dec 2023 [monthly]

    Recruiting PHASE3

    First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kilimanjaro Christian Medical Centre, Tanzania
  • London School of Hygiene and Tropical Medicine
  • National Institute for Medical Research, Tanzania
Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations